Skip to main content

Test Price

550 AED

✅ Home Collection Available

Alpha-Fetoprotein (AFP) Immunohistochemistry Test in UAE | 550 AED | 2026 DHA Guidelines
تحليل ألفا فيتو بروتين (AFP) بالكيمياء النسيجية المناعية في الإمارات | 550 درهم | معتمد من هيئة الصحة بدبي

Clinical Certainty & Premium UAE Service

  • Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited processing, ensuring definitive AFP immunoexpression profiling.
  • Premium Logistics: Complimentary hospital-grade home collection with ISO-certified cold-chain transport and VIP mobile phlebotomy for tissue/biopsy specimens across all Emirates.
  • Clinical Guidance: Complimentary post-test telephonic interpretation session with a senior pathologist, aligning results with your full histopathology and clinical context.
  • Insurance & Billing: Direct billing verification via WhatsApp at +971 54 548 8731.

Test Overview

The Alpha-Fetoprotein (AFP) Immunohistochemistry test definitively identifies AFP protein expression within tumour cells, guiding oncologists and surgical pathologists in confirming hepatocellular or germ cell differentiation. It is the tissue-based gold standard for primary liver cancer and gonadal tumour subtyping, directly impacting staging and treatment decisions.
يُحدد اختبار الكيمياء النسيجية المناعية لبروتين ألفا فيتو (AFP) بشكل قاطع وجود البروتين داخل الخلايا السرطانية، مما يوجه أطباء الأورام وأطباء الأمراض الجراحية لتأكيد تمايز الخلايا الكبدية أو الخلايا الجرثومية، وهو المعيار الذهبي النسيجي لتشخيص سرطان الكبد الأولي وأورام الغدد التناسلية.

Feature Our Test (Tissue IHC) Closest Alternative (Serum AFP)
Precision & Localisation Single-cell resolution within tumour tissue; no confounding by liver injury Blood level; non-specific rise in cirrhosis, hepatitis
Methodology Immunohistochemistry (Polymer DAB, automated platform) on FFPE block Serum chemiluminescent immunoassay
Speed 5–7 business days (report) Same day
Clinical Weight Confirmatory for tumour origin & required before targeted therapy Screening/monitoring; not diagnostic alone

Physician Insight & Safety Protocol

“As a DHA-licensed clinical pathologist, I emphasise that AFP immunohistochemistry is a powerful adjunct but must always be correlated with morphology and other markers. A positive stain supports hepatocellular or germ cell lineage but never replaces complete histopathological assessment. Please consult your managing oncologist before interpreting this result in isolation.”

— Dr. PRABHAKAR REDDY, DHA License: 61713011

Medication Warning: Do not discontinue any prescribed medication, especially anticoagulants or chemotherapy, without direct instruction from your treating physician. This test result does not modify ongoing therapy without specialist review.

Patient Safety Exclusion Criteria & Emergency Red Flags

  • Exclusion: Specimen with no accompanying histopathology report, biopsy site or clinical history.
  • Exclusion: Non‑tumour tissue, cytology samples, or severely autolysed/necrotic specimens.
  • Exclusion: Insufficient tumour cell content for reliable staining.
  • ER Red Flag: If you develop sudden severe abdominal pain, jaundice, vomiting blood, or signs of acute liver failure (confusion, bleeding) after biopsy, seek immediate emergency care.
  • ER Red Flag: Any new lump, testicular swelling, or neurological symptoms require urgent oncological evaluation irrespective of AFP IHC results.

Patient FAQ & Clinical Guidance

What does a positive AFP immunohistochemistry result mean for my cancer diagnosis?

Snippet: A positive AFP stain on tumour tissue indicates primary liver cancer or germ cell tumour. Further subtyping with additional markers (e.g., HepPar1, CK7, OCT4) is performed to pinpoint the exact entity. This result is integrated into your full pathology report by a consultant pathologist.

تعني نتيجة إيجابية لصبغة AFP في النسيج الورمي وجود سرطان كبد أولي أو ورم خلايا جرثومية، ويتم دمجها مع التحليل النسيجي الكامل لتحديد النوع الدقيق.

Is a biopsy mandatory for AFP immunohistochemistry testing?

Snippet: Yes, a biopsy or surgical tissue sample is required to perform immunohistochemistry staining for AFP. The test uses the same formalin‑fixed paraffin‑embedded (FFPE) block submitted for routine histopathology; no additional invasive procedure is needed.

نعم، يلزم أخذ خزعة أو عينة نسيجية جراحية لإجراء صبغة الكيمياء النسيجية المناعية لـ AFP، ويُستخدم نفس قالب البارافين المُثبَّت بالفورمالين.

How should I prepare before the tissue sample collection?

Snippet: No special preparation is needed as the uses tumour tissue already collected during biopsy. The sample is fixed immediately in formalin and sent to the laboratory with your histopathology report, biopsy site and clinical history.

لا حاجة لتحضيرات خاصة، حيث تُستخدم الأنسجة المأخوذة أثناء الخزعة وتُثبَّت بالفورمالين وتُرسل مع تقرير الأنسجة وموقع الخزعة والتاريخ السريري.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians